Login / Signup

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Elise van MulligenAngelique E WeelTjallingius Martijn KuijperN H A M DenissenAndreas H GerardsMike H de JagerWai-Kwan Lam-TseJ M HazesAnnette H M van der Helm van MilPascal Hendrik Pieter de JongJolanda J Luime
Published in: Annals of the rheumatic diseases (2020)
NTR2754.
Keyphrases
  • rheumatoid arthritis
  • phase iii
  • study protocol
  • disease activity
  • phase ii
  • clinical trial
  • interstitial lung disease
  • ankylosing spondylitis
  • open label
  • randomized controlled trial